Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

XTL Biopharmaceuticals Ltd. XTLB

Full chart Compare
Set alert

Price alert · XTLB

All alert types
1.55 USD -0.17 (-9.76%)

At closeNov 6, 2026, 4:00 PM EST

1.55 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

1.55 Day range 1.68
1.55 52-week range 4.28
YTD
-33.19%
1 year
-61.25%

Revenue & Expenses

Other Income → Expenses: $1.01MExpenses → Selling, General & Admin: $2.05MExpenses → Research & Development: $98.00KExpenses → Other Operating Expenses: $31.00KIncome Tax Benefit → Expenses: $130.00KGross Profit → Expenses: $3.00KRevenue → Gross Profit: $3.00KRevenue → Cost of Revenue: $448.00KNet Loss → Expenses: $1.03MOther Income$1.01MIncome Tax Benefit$130.00KGross Profit$3.00KNet Loss$1.03MCost of Revenue$448.00KExpenses$2.17MSelling, General & Admin$2.05MResearch & Development$98.00KOther Operating Expenses$31.00KRevenue$451.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
XTLB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-1.69M-775.00K-765.00K-880.00K-1.03M
-6.97M-1.03M-1.78M-1.35M435.00K
-3.20-0.80-1.20-0.80—

Balance sheet

Full balance sheet How to read it
XTLB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
76.00K371.00K1.40M2.09M2.97M
166.00K8.55M2.43M4.19M6.62M
420.00K3.12M206.00K187.00K1.28M
269.00K138.00K000
-254.00K5.43M2.22M4.00M5.33M

Cash flow

Full cash flow How to read it
XTLB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-1.02M-1.62M-707.00K-901.00K-1.05M
522.00K-844.00K41.00K36.00K8.00K
208.00K1.45M00385.00K
-295.00K-1.01M-666.00K-865.00K-656.00K